Quick Search 
Drugs of the Future
Register or sign in

  
 
  
Volume 43, Issue 3, March 2018, Pages 161-227
 
MONOGRAPHS
 
  
 Murepavadin.
Outer membrane protein-targeting antibiotic, Inhibitor of LptD-mediated lipopolysaccharide (LPS) transport, Treatment of Pseudomonas aeruginosa respiratory infections.
Chopra, S., Thakare, R., Dasgupta, A.
Drugs Fut 2018, 43(3): 161
Summary | Full Text: PDF 
 
  
  
 Olumacostat glasaretil.
Acetyl-CoA carboxylase (ACC) inhibitor, Acne therapy.
Baroudi, B., Shealy, E.R., Cardwell, L.A., Alinia, H., Feldman, S.R.
Drugs Fut 2018, 43(3): 175
Summary | Full Text: PDF 
 
  
  
 Sitravatinib.
Multitargeted tyrosine kinase inhibitor, Treatment of solid tumors.
Gajdosik, Z.
Drugs Fut 2018, 43(3): 181
Summary | Full Text: PDF 
 
  
 
TARGETS TO WATCH
 
  
 Therapeutic targets for hepatitis D virus infection.
Sorbera, L., Dulsat, C., Graul, A.I.
Drugs Fut 2018, 43(3): 189
Summary | Full Text: PDF 
 
  
 
BIOMARKERS TO WATCH
 
  
 Biomarker snapshots – neurological and psychiatric disorders.
Bofill, X., Cole, P., Dulsat, C.
Drugs Fut 2018, 43(3): 193
Summary | Full Text: PDF 
 
  
 
DRUGLINE
 
  
 Pipeline on the move.
Torramade, E., Gonzalez Brao, M.M., Mila, M.
Drugs Fut 2018, 43(3): 199
Full Text: PDF 
 
  
 
MEETING REPORTS
 
  
 Recent trends and technologies towards medicines of the future. A joint meeting of the SMR and the RSC BMCS. London, UK – December 8, 2017.
Pryde, D.C., Ahmad, N.M., Swarbrick, M.E.
Drugs Fut 2018, 43(3): 215
Summary | Full Text: PDF 
 
  
  
 American Academy of Dermatology (AAD) – 76th Annual Meeting. San Diego, California, USA – February 16-20, 2018.
Watt, J.
Drugs Fut 2018, 43(3): 225
Summary | Full Text: PDF 
 
  
 
  



© 2022 Clarivate. All rights reserved.
Copyright NoticeTerms of UsePrivacy StatementCookie PolicyManage cookie preferences